Ankylosing spondylitis is a long-term disease that causes inflammation of the joints between the spinal bones, and the joints between the spine and pelvis. It eventually causes the affected spinal bones to join together.
Your doctor may prescribe nonsteroidal anti-inflammatory drugs (NSAIDs) to reduce inflammation and pain.
Corticosteroid therapy or medications to suppress the immune system may also be prescribed. Drugs called TNF-inhibitors (etanercept, adalimumab, infliximab), which block an inflammatory protein, have been shown to improve the symptoms of ankylosing spondylitis.
Some health care professionals use drugs that block cell growth (cytotoxic drugs) in people who do not respond well to corticosteroids or who are dependent on high doses of corticosteroids.
Surgery may be done if pain or joint damage is severe.
Exercises can help improve posture and breathing. Lying flat on the back at night can help maintain normal posture.
Outlook (Prognosis)
The course of the disease is unpredictable. Symptoms may come and go at any time. Most people are able to function unless the hips are severely involved.
Possible Complications
Rarely, people may have problems with the aortic heart valve (aortic insufficiency) and heart rhythm problems.
Some patients may have pulmonary fibrosis or restrictive lung disease.
When to Contact a Medical Professional
Call your health care provider if:
You have symptoms of ankylosing spondylitis
You have ankylosing spondylitis and develop new symptoms during treatment
Prevention
Prevention is unknown. Awareness of risk factors may allow early detection and treatment.
Sidiropoulos PI, Hatemi G, Song IH, et al. Evidence-based recommendations for the management of ankylosing spondylitis: systematic literature search of the 3E Initiative in Rheumatology involving a broad panel of experts and practising rheumatologists. Rheumatology (Oxford). 2008. 47(3):355-61.
Dagfinrud H, Kvien TK, Hagen KB. Physiotherapy interventions for ankylosing spondylitis. Cochrane Database, Syst Rev. 2008. (1):CD002822.
Review Date:
5/31/2009
Reviewed By:
Mark James Borigini, Associate Clinical Professor of Medicine, University of California, Irvine, Irvine, CA. Review provided by VeriMed Healthcare Network. Also reviewed by David Zieve, MD, MHA, Medical Director, A.D.A.M., Inc.